Back
Office Properties Income Trust Vs. Novartis AG Industry Stock Comparison
Sell
19
OPI
Office Properties Income Trust
Last Price:
$0.59
Seasonality Move:
0.86%
Buy
71
NVSEF
Novartis AG
Last Price:
$116.60
Seasonality Move:
6.56%
Sell
19
Office Properties Income Trust (OPI)
is a Sell
Is Office Properties Income Trust a Buy, Sell or Hold?
-
The current Office Properties Income Trust [OPI] share price is $0.59. The Score for OPI is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
OPI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
71
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $116.60. The Score for NVSEF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
OPI Stock Price Chart
What is Office Properties Income Trust's stock price today?
-
The Office Properties Income Trust share price today is $0.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPI is experiencing slight buying pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $116.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
OPI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 29.19 | Sell |
| Chaikin Money Flow: | 151920 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.72 - 0.94) | Sell |
| Bollinger Bands (100): | (0.8 - 1.42) | Sell |
NVSEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.84 | Buy |
| Relative Strength Index (14 RSI): | 61.26 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (107.1 - 113.78) | Buy |
| Bollinger Bands (100): | (98.55 - 109.41) | Buy |
OPI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.69 | Sell |
| 20-day SMA: | 0.81 | Sell |
| 50-day SMA: | 0.88 | Sell |
| 200-day SMA: | 1.67 | Sell |
| 8-day EMA: | 0.68 | Sell |
| 20-day EMA: | 0.78 | Sell |
| 50-day EMA: | 0.91 | Sell |
| 200-day EMA: | 1.77 | Sell |
NVSEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.96 | Buy |
| 20-day SMA: | 111.23 | Buy |
| 50-day SMA: | 106.01 | Buy |
| 200-day SMA: | 106.77 | Buy |
| 8-day EMA: | 112.31 | Buy |
| 20-day EMA: | 110.66 | Buy |
| 50-day EMA: | 107.55 | Buy |
| 200-day EMA: | 104.74 | Buy |
Office Properties Income Trust Earnings Growth & OPI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.51 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Office Properties Income Trust Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novartis AG Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||